Description
Recombinant monoclonal antibody to CD257 (BAFF). Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma H1104-30.
Target
CD257 (BAFF)
Target Alias Names
BLyS, TNFSF13B, TALL-1, TNFSF20, ZTNF4, Tumor necrosis factor ligand superfamily member 13B, B lymphocyte stimulator, B-cell-activating factor, Dendritic cell-derived TNF-like molecule, TNF and APOL-related leukocyte expressed ligand 1
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression